American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1966)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (6)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1363)

Results (4048)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib/II trial of ribociclib in combination with binimetinib in patients with NRAS-mutant melanoma
    Journal Article

    Schuler, M.; Zimmer, L.; Kim, K. B.; Sosman, J. A.; Ascierto, P. A.; Postow, M. A.; De Vos, F. Y. F. L.; van Herpen, C. M. L.; Carlino, M. S.; Johnson, D. B.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Telaglenastat plus everolimus in advanced renal cell carcinoma: A randomized, double-blinded, placebo-controlled, phase II ENTRATA trial
    Journal Article

    Lee, C. H.; Motzer, R.; Emamekhoo, H.; Matrana, M.; Percent, I.; Hsieh, J. J.; Hussain, A.; Vaishampayan, U.; Liu, S.; McCune, S.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Orthovoltage X-rays exhibit increased efficacy compared with γ-rays in preclinical irradiation
    Journal Article

    Bell, B. I.; Vercellino, J.; Brodin, N. P.; Velten, C.; Nanduri, L. S. Y.; Nagesh, P. K. B.; Tanaka, K. E.; Fang, Y.; Wang, Y.; MacEdo, R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types
    Journal Article

    Sinha, N.; Sinha, S.; Valero, C.; Schäffer, A. A.; Aldape, K.; Litch, K.; Chan, T. A.; Morris, L. G. T.; Ruppin, E.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Replication of overall survival, progression-free survival, and overall response in chemotherapy arms of non-small cell lung cancer trials using real-world data
    Journal Article

    Ton, T. G. N.; Pal, N.; Trinh, H.; Mahrus, S.; Bretscher, M. T.; Machado, R. J. M.; Sadetsky, N.; Chaudhary, N.; Lu, M. W.; Riely, G. J.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A randomized phase II study of MEDI0680 in combination with durvalumab versus nivolumab monotherapy in patients with advanced or metastatic clear-cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Azad, A. A.; Hansen, A. R.; Gray, J. E.; Welsh, S. J.; Song, X.; Kuziora, M.; Meinecke, L.; Blando, J.; Achour, I.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Plasma protein biomarkers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: Results from CALGB 80405 (Alliance)
    Journal Article

    Nixon, A. B.; Sibley, A. B.; Liu, Y.; Hatch, A. J.; Jiang, C.; Mulkey, F.; Starr, M. D.; Brady, J. C.; Niedzwiecki, D.; Venook, A. P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Ultrasmall nanoparticle delivery of doxorubicin improves therapeutic index for high-grade glioma
    Journal Article

    Aragon-Sanabria, V.; Aditya, A.; Zhang, L.; Chen, F.; Yoo, B.; Cao, T.; Madajewski, B.; Lee, R.; Turker, M. Z.; Ma, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • The role of the TP53 pathway in predicting response to neoadjuvant therapy in esophageal adenocarcinoma
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; De La Torre, S.; Janjigian, Y. Y.; Maron, S. B.; Ku, G. Y.; Tang, L. H.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: